8/29/2020 Glenmark Pharma | Consolidated Profit & Loss account > Pharmaceuticals > Consolidated Profit & Loss

mp; Loss account of Glenmark Phar…

This data can be easily copy pasted into a Microsoft Excel sheet PRINT
Glenmark Pharma Previous Years »
Consolidated Profit & Loss
------------------- in Rs. Cr. -------------------
account
Mar 20 Mar 19 Mar 18 Mar 17 Mar 16

12 mths 12 mths 12 mths 12 mths 12 mths

INCOME
Revenue From Operations [Gross] 10,640.97 9,705.08 8,972.23 8,970.09 7,457.92
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 28.65 106.27 87.91
Revenue From Operations [Net] 10,640.97 9,705.08 8,943.58 8,863.82 7,370.01
Other Operating Revenues 0.00 160.38 130.84 215.60 191.66
Total Operating Revenues 10,640.97 9,865.47 9,074.42 9,079.41 7,561.67
Other Income 159.60 208.14 91.40 37.37 20.00
Total Revenue 10,800.57 10,073.61 9,165.82 9,116.78 7,581.67
EXPENSES
Cost Of Materials Consumed 2,541.47 2,444.71 2,150.11 2,354.81 1,928.75
Purchase Of Stock-In Trade 1,029.08 976.30 754.75 719.12 514.00
Changes In Inventories Of FG,WIP And
128.08 -58.67 133.71 -459.61 -140.16
Stock-In Trade
Employee Benefit Expenses 2,254.78 2,056.07 1,871.84 1,640.81 1,378.20
Finance Costs 377.32 334.59 285.57 237.32 178.89
Depreciation And Amortisation Expenses 417.17 325.91 301.88 264.37 234.28
Other Expenses 2,989.47 2,861.26 2,548.64 2,787.58 2,443.74
Total Expenses 9,737.37 8,940.16 8,046.49 7,544.40 6,537.69
Profit/Loss Before Exceptional,
1,063.20 1,133.45 1,119.33 1,572.38 1,043.98
ExtraOrdinary Items And Tax
Exceptional Items 32.88 167.18 0.00 -80.95 0.00
Profit/Loss Before Tax 1,096.08 1,300.63 1,119.33 1,491.43 1,043.98
Tax Expenses-Continued Operations
Current Tax 320.11 476.54 325.69 619.04 511.44
Deferred Tax 0.00 -100.91 -10.23 -236.37 -210.50
Total Tax Expenses 320.11 375.64 315.46 382.68 300.94
Profit/Loss After Tax And Before
775.97 924.99 803.87 1,108.75 743.05
ExtraOrdinary Items
Profit/Loss From Continuing
775.97 924.99 803.87 1,108.75 743.05
Operations
Profit/Loss For The Period 775.97 924.99 803.87 1,108.75 743.05
Consolidated Profit/Loss After MI And
775.97 924.99 803.87 1,108.75 743.05
Associates
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 28.00 33.00 28.00 39.00 26.00
Diluted EPS (Rs.) 28.00 33.00 28.00 39.00 26.00
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 0.00 68.03 67.92 67.95 67.92

Source : Dion Global Solutions Limited

https://www.moneycontrol.com/stocks/company_info/print_main.php 1/2
8/29/2020 Glenmark Pharma | Consolidated Profit & Loss account > Pharmaceuticals > Consolidated Profit & Loss account of Glenmark Phar…

https://www.moneycontrol.com/stocks/company_info/print_main.php 2/2